Heather Rees - Oct 6, 2023 Form 3 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
SVP, Finance and Accounting
Signature
/s/ Heather Rees
Stock symbol
ATOS
Transactions as of
Oct 6, 2023
Transactions value $
$0
Form type
3
Date filed
10/16/2023, 04:00 PM
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 32.5K $1.48 Direct F1
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 23.5K $3.18 Direct F1
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 130K $2.90 Direct F1
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 100K $3.18 Direct F1
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 150K $0.93 Direct F2
holding ATOS Stock Option (Right to Buy) Oct 6, 2023 Common Stock 226K $0.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested.
F2 The options vest in equal quarterly installments over a period of two years from the grant date, May 13, 2022, subject to the Reporting Person's continued service to Issuer through each vesting date.
F3 The options vest in equal quarterly installments over a period of two years from the grant date, June 12, 2023, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney